6th International Veterinary Vaccines and Diagnostics Conference

The First  IVVDC Conference was held in Madison WI in 1997 (Chair R.D. Schultz), the 2nd in Oxford England 2000 (Chair Lewis Thomas), the 3rd in Guelph Canada 2003 (Chair Pat Shewen)  the 4th in Oslo Norway 2006 (Chair Arve Lund) and the 5th in Madison, USA (Chair Ronald David Schultz) .  These were all excellent conferences!  The original and continuing purpose of the IVVDC is to bring together people from the Private Sector (Industry, Veterinary Practice) and the Public Sector (Government and Academia) to discuss issues pertaining to the development and use of all Veterinary Vaccines and Diagnostics for multiple animal species.  The 6th IVVDC will be located in an ideal setting, in the beautiful city of Cairns in Australia’s tropical East Coast near the Great Barrier Reef. We hope to see many old faces and some new as we continue to make major inroads into Veterinary Immunology, Microbiology, Vaccinology and Diagnostics.

Keynote speaker: Dr Paul Wood, outgoing Executive Director, Global Discovery, Pfizer Animal Health Title: Current status of Veterinary Biologicals and opportunities and challenges for the future
 
Opening Plenary Speaker: Prof Joe Brownlie, Royal Veterinary College, UKTitle: Vaccine development from research to market
   
Invited Symposium  Speakers & Presentation titles:
Deborah Middleton, CSIRO, Australia – Towards a Hendra virus vaccine for horses
Ron Schultz, University of Wisconsin, USA – All the important information you need to know about canine and feline vaccines and immunity to them
Hiroshi Kida, Hokkaido University, Japan – For the control of avian and human pandemic influenza
Dave Jackson, University of Melbourne, Australia – Novel methods for vaccine delivery   
Marc Mansour, Immunovaccine, USA – Novel depot based formulations for long lasting single dose vaccines
Marian Horzinek, SPES NOSTRA, Haydnlaan, Bilthoven, The Netherlands – An overview of The European Advisory Board on Cat Diseases (ABCD) and its achievements so far.
Kimberly Cole, Ohio State University, USA – Salmonella as a vaccine vector
Barbara Nowak,    University of Tasmania, Australia – Improving vaccine performance through understanding host-pathogen interaction in yersiniosis
Jules Minke, Merial, USA – The use of ALVAC as a technology platform for veterinary vaccines
Further oral presentations will be selected from submitted abstracts

For more information and to register, please visit http://www.ivvdc2012.org/